RepsBio: Participating projects won the Second Prize of National Science and Technology Progress Award.

Replibio announced that the project "Key Technologies and Applications of Avian Influenza Vaccine Creation and Source Prevention" participated by the company and its holding subsidiary South Biotech recently won the second prize of the National Science and Technology Progress Award. The company undertakes the joint development of achievements and relies on core technology research and development to develop a series of avian influenza vaccines that have been approved, with core indicators leading the industry. Some products have been exported overseas. This award demonstrates the company's technological accumulation, which will have a positive impact on future development and no significant impact on recent performance.